France, which ranks world’s number three in sales (€51.5bn) and is Europe’s number three for drug manufacturing.
Biotech and Pharmaceuticals sector in France
France, which ranks world’s number three in sales (€51.5bn) and is Europe’s number three for
drug manufacturing with 210 production sites, is an attractive location in which to do business
and set up operations.
The biopharma sector is made of:
ξ world leaders/large companies,
ξ innovative SMEs,
ξ world-class public/private scientific research expertise.
Half of them located in the Paris or Lyon areas.
ξ 257 pharmaceutical firms and 250 biotech firms in 2011.
ξ The industry employed 104,000 people, including 22,000 in R&D in 2011.
ξ 12.5% of sales revenue dedicated to R&D with €8 bn invested in 2010.
Key government initiatives
ξ World-class competitiveness clusters: Medicen (Paris), LyonBiopole (Lyon-Grenoble),
ξ R&D tax credit
ξ €22 billion allocated to the “Grand Emprunt”, Future Investments Programme, and FSI
(Investment Strategic Fund).
1. Numerous opportunities for future growth:
ξ novel approaches to patient care;
ξ “grey-gold” market with an ageing population;
ξ emerging technologies (platform technologies, micro/nanotechnologies and
ξ increased number of industry and academia collaboration projects and partnerships (85 in
2. Fast growing/high-value segments:
ξ Preventive and therapeutic vaccines (nr 2 world leader: Sanofi Pasteur)
ξ Diagnostics/theranostics (world leader: BioMérieux)
ξ Animal health products (world leader: Mérial)
ξ 39 biomanufacturing sites
ξ Personal care/cosmetics: France is a world leader with L’Oréal and Pierre Fabre
ξ Generics and biosimilars
ξ Non-pharmaceutical products/OTCs
3. Become a Research Tax Credit approved R&D organisation to be more competitive in
4. Reply to business opportunities and calls for tenders.
Key UKTI business events
ξ Life science/Healthcare East Midlands mission (Summer 2012 – dates tbc);
ξ Franco-British business exchange on Personal Care R&D challenges, with Intelligent
Formulation, Pharma Valley and Cosmetic Valley, Normandy, 15-16 Oct. 2012;
ξ Genesis conference, London, 13 Dec. 2012.
Latest export opportunities – Biotechnology & Pharmaceuticals
Latest export opportunities – France
Getting into the market
ξ Official certification and/or CE-marking necessary.
ξ Easy communication: English is widely spoken in this sector.
ξ Key elements of company/product information and USPs to be ideally translated into
More about doing business in France
Market intelligence is critical when doing business overseas, and UKTI can provide bespoke
market research and support during overseas visits though our chargeable Overseas Market
Introduction Service (OMIS).
To commission research or for general advice about the market, get in touch with our specialists
in country - or contact your local international trade team.
ξ Laurent Faye, British Trade & Investment Office Lyon Tel: +33 (0)4 72 62 99 56 or
ξ Anne-Marie Coffy, British Trade & Investment Office Lyon Tel: +33 (0)4 72 62 99 60 or
Contact your local international trade team
UKTI runs a range of events for exporters, including seminars in the UK, trade missions to
overseas markets and support for attendance at overseas trade shows.
Innovation Days 2012
Paris, France,1-3 October 2012
Lille, France, 3-4 December 2012
Latest events – Biotechnology & Pharmaceuticals
More about OMIS and other UKTI services for exporters